Ron Squarer, CEO at ARRAY BIOPHARMA INC (ARRY), sold 273,438 shares at $10.73 ($2.9M) on 2017-12-18, disclosed to the SEC on 2017-12-19.
Open-market sale of $2.9M ARRY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2019-02-01 | $6.0M | — | Filing → |
| ARRY | SELL | 2018-06-29 | $6.6M | — | Filing → |
| ARRY | SELL | 2017-12-19 | $8.9M | — | Filing → |